Printer Friendly Version
Paul Sudentas is an associate in the New York office of Locke Lord LLP where he concentrates on complex patent litigation matters, with an emphasis on pharmaceuticals and biotechnology. Paul has represented and counseled both branded and generic pharmaceutical companies in matters arising under the Hatch-Waxman Act. Paul has extensive experience in all facets of Hatch-Waxman litigation including developing strategies related to validity and infringement issues, preparing notice letters, fact discovery, expert discovery, claim construction issues, dispositive motions, preliminary injunction motions, and trial, among others. Paul also has medical device and biotechnology experience which includes developing strategies related to validity and infringement issues and preparing opinions of counsel.
In addition, Paul counsels clients on various transactional matters in and out of the life sciences industry.
News, Events, Notable Matters, and More
Showing Results for
Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.